Profession · Quality · Innovation

About Taikun

Taikun Pharma, Global Clinical Trial Services Expert

As the expert in global clinical services, Taikun Pharma provides bespoke clinical trial services solutions for our clients.


Whether it's optimizing flexibility in clinical supply timelines or assisting with regulatory guidelines and packaging design, Taikun Pharma is committed to delivering client centric solutions to support the success of clinical trials globally.


Through our GDP/GMP compliant facilities located in America, Belgium, Australia and China, and our partner depot network across North America, South America and Europe, Taikun Pharma provides a full range of clinical trial services. These services include:

  • Specialized clinical supply management
  • GCP/GMP compliant packaging solutions
  • Label and carton design and manufacturing
  • Temperature-controlled storage
  • Clinical site distribution
  • Import & export of clinical materials
  • QP services (auditing, QP declaration and QP certification of imps)
  • Returns and destruction services
  • IRT solution
  • 12,000+/Year
    Distribution
  • 600+
    Completed & On-going Projects/Trials
  • 350+
    Served BioPharma Companies
  • 50+
    Global Cities We Ship to

Our History

2019-2022

Established in 2019, Taikun Pharma Services began in Melbourne, Australia.  Our vision has always been to become a leader in clinical supply management services in the Asia Pacific region but, just as important, an important global player.


Taikun Pharma Services offers a full range of clinical trial services at our GDP/GMP-compliant facilities located in Melbourne, Australia and Shanghai, China, as well as throughout our partner depot network in  southeast Asia, North America, South America, and Europe. 


After successfully delivering hundreds of clinical studies in the Asia Pacific region by way of a comprehensive project management approach, focused on high-quality standards, Taikun Pharma Services has quickly become a leading regional clinical supply services provider.

2023

Expansion into the U.S. market by opening our own GMP compliant facility in New Jersey provided us the ability to begin servicing both U.S. local and international sponsors.


Our Taikun Pharma Services U.S. facility, situated near the prestigious Princeton University research precinct, spans approximately 10,000 square feet and boasts offerings in the clinical packaging space, along with storage solutions within various temperature-controlled environments, meeting a wide variety of study requirements.  


Upholding our principle of “Drug development comes first because patients are our top priority,” we leverage our deep, local project delivery experience and global expertise to provide flexible clinical packaging and storage solutions to sponsors around the world.

2024

2024 marked the launch of the Taikun Pharma Services IRT solution, OZONE ONE, into the global market.


OZONE ONE is a smart and reliable IRT solution designed and implemented to navigate study complexities and improve the traditional IRT user experience.  This marks a significant milestone for Taikun Pharma Services as we continue leading industry innovation by providing integrated services to overlay clinical drug supply management with IRT functionality. 


2024 also marked the establishment and obtained EU GMP certification of Taikun Europe in Brussels, Belgium, adding an integral part to the Taikun global depot network. Taikun Europe is well-positioned to a offer full range of clinical supply services, including QP Release in support of sponsors’ international studies. 


2019-2022
2023
2024

Partners

Client Testimonial

"High Quality Standard and Highly Experienced Team"

"Flexibility Of Services and Special/Urgent Needs Can Be Dealt With"

"Competitive Pricing and Tailored Solution"

"4.5/5 Satisfaction"

  • Our flexibility, tailored solutions and quality of services distinguish us.
  • Over 98% of our current clients would recommend Taikun services for clinical services needs, according to our 2023 NPS Survery.